Generic Drugs Forum 2022: The Current State of Generic Drugs – FDA.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Webcast
Visit CDER Small Business and Industry Assistance Page
Agenda
Sign up for Industry Updates

Sally Choe, Ph.D.
Director
Office of Generic Drugs (OGD) | CDER | FDA
 

Michael Kopcha, Ph.D., R.Ph.
Director
Office of Pharmaceutical Quality (OPQ) | CDER | FDA
 
The Generic Drugs Forum (GDF) is an annual, two-day virtual event that offers attendees the opportunity to hear from FDA subject matter experts from every part of the generic drug assessment program. The goal of the forum is to provide information to aid potential and current applicants by offering practical advice, presenting case studies, and taking a deep dive into the Abbreviated New Drug Application (ANDA) assessment process.
This year’s theme is The Current State of Generic Drugs and presentations will focus on hot topics such as the pre-ANDA program, generic drug metrics, post-market safety, pre-approval inspections, and global generic drug affairs.
The generic drug industry, consultants, regulatory affairs professionals, or contractors with an emphasis on those who:
Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event.
This course has been:
03/11/2022
More Meetings,
Conferences, and
Workshops

source

Add a Comment

Your email address will not be published. Required fields are marked *